Abstract
Feasibility and Outcomes of T-Cell Depleted Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory AML and High Risk MDS
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have